| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |